17q12 microdeletion syndrome

Lore & Background

17q12 microdeletion syndrome is an autosomal dominant disorder, where one copy of the relevant mutation is enough to cause the condition. Most cases are de novo, or spontaneous mutations that do not occur in the proband's parents; approximately 75% are de novo, while 25% are inherited. People with 17q12 microdeletions who have normal fertility have a 50% chance of passing the deletion down to their offspring. Environmental factors have not been implicated in the syndrome.

The condition has a variable phenotype, ranging from few or no symptoms to severe disability. The most characteristic symptom is renal cysts and diabetes syndrome (RCAD), also known as MODY 5, which is caused by deletion of the associated HNF1B gene. RCAD is diagnosed in approximately 40% of people with 17q12 microdeletions, usually prior to age 25, while kidney abnormalities more broadly occur in approximately 85-90%. People with 17q12 microdeletions have a characteristic facial phenotype, albeit a subtle one not usually obvious in daily life. Macrocephaly is common, along with high arched eyebrows, flattening of the malar region, and epicanthic folds.

17q12 microdeletions are associated with neurocognitive and developmental involvement of variable severity. Some have mild to moderate intellectual disability; however, such impairment is not universal. Speech delay is common, regardless of intellectual functioning. The most striking association is the raised prevalence of autism spectrum disorder, with significant increases in both diagnosis and subclinical autistic traits. Schizophrenia is also a significant psychiatric complication. Epilepsy, usually mild, occurs in approximately one-third of cases. Reproductive system anomalies are associated, particularly in females, including uterine malformations and Müllerian agenesis.

Reader's Guide

17q12 microdeletion syndrome is significant as a rare genetic disorder that bridges multiple medical specialties, including nephrology, endocrinology, psychiatry, and developmental pediatrics. Its association with renal cysts and diabetes syndrome (RCAD) provides a clear genetic basis for a subset of diabetes and kidney disease, while its strong link to autism spectrum disorder and schizophrenia highlights the role of chromosomal microdeletions in neuropsychiatric conditions. The syndrome is estimated to occur in approximately 1 in 600 people on the autism spectrum and 1 in 1,600 with schizophrenia, compared to a general population prevalence between 1 in 14,000 and 1 in 62,500, indicating it is a major genetic contributor to these conditions. The condition is thought to be underdiagnosed, and cases with milder phenotypes may not reach clinical attention unless they have an affected child themselves. Diagnosis is via fluorescence in situ hybridization, as traditional karyotyping is rarely sensitive enough. Treatment is symptomatic and supportive, with routine monitoring of renal function and caution regarding medications that may affect glucose metabolism or kidney function. The syndrome is not to be confused with 17q12 microduplication syndrome or 17q21.31 microdeletion syndrome (Koolen–De Vries syndrome).

Did You Know?

• 17q12 microdeletion syndrome is estimated to occur in approximately 1 in 600 people on the autism spectrum and 1 in 1,600 with schizophrenia.
• Renal cysts and diabetes syndrome (RCAD) is diagnosed in approximately 40% of people with 17q12 microdeletions, usually prior to age 25.
• Approximately 75% of cases are de novo (spontaneous mutations), while 25% are inherited.
• The condition occurs in approximately 3-6% of women with Müllerian agenesis.

The Clinical Face of 17q12

The clinical picture of 17q12 microdeletion syndrome is remarkably heterogeneous, spanning from virtually asymptomatic individuals to those facing profound disability. This wide spectrum means the condition is widely regarded as underdiagnosed; milder presentations often escape clinical notice until an affected child prompts family screening. The hallmark feature is renal cysts and diabetes syndrome, sometimes called MODY 5, which stems from the loss of the HNF1B gene. Roughly forty percent of carriers develop this condition, typically before their mid-twenties, while kidney structural abnormalities affect the vast majority at eighty-five to ninety percent. Yet a subset retains entirely normal kidney function. Beyond the kidneys, a subtle but recognizable facial pattern emerges: enlarged head circumference, high-set arched brows, a flattened cheek area, and epicanthic folds. A shorter, stockier build and pathological short stature appear in many cases. In females, reproductive tract anomalies—most notably Müllerian agenesis, in which the uterus and upper vaginal canal are absent—represent a distinctive and serious complication.

Neurodevelopmental and Psychiatric Dimensions

The neurological and psychiatric footprint of 17q12 microdeletion is as variable as its physical one. Intellectual functioning ranges from mild to moderate disability in some individuals, though impairment is far from universal; those without significant cognitive deficits typically score in the average to low-average range. Speech delay is a common finding, appearing regardless of overall intellectual capacity. Perhaps the most striking neurodevelopmental association is the markedly elevated prevalence of autism spectrum disorder. The deletion is recognized as one of the principal genetic contributors to high-functioning autism, with both formal diagnoses and subclinical autistic traits significantly more common than in the general population. Schizophrenia represents another major psychiatric risk: the deletion is found in roughly one in sixteen hundred individuals with schizophrenia, compared to a background frequency below one in fifty thousand. Epilepsy, when present, tends to be mild and affects approximately one-third of those carrying the deletion.

Genetics, Inheritance, and How It Is Found

17q12 microdeletion syndrome follows an autosomal dominant pattern, meaning a single missing copy of the relevant chromosomal segment is sufficient to produce the condition. The majority of cases—roughly three-quarters—arise as de novo events, spontaneous mutations absent in both parents, while the remaining quarter is inherited from a carrier parent. For those with normal fertility, each pregnancy carries a fifty percent chance of transmitting the deletion. No environmental triggers have been identified as causative. Because the deleted segment is too small for conventional karyotyping to resolve, diagnosis relies on fluorescence in situ hybridization, a technique specifically designed to detect micro-scale chromosomal changes. Epidemiologically, the condition is estimated to affect between one in fourteen thousand and one in sixty-two thousand and a half people overall. Its prevalence is substantially enriched in specific clinical groups: about one in six hundred on the autism spectrum, one in sixteen hundred with schizophrenia, two percent among those with congenital kidney malformations, and three to six percent of women presenting with Müllerian agenesis. It also ranks among the ten most common microdeletions in children with unexplained developmental delay.

Living With the Diagnosis and the Microduplication Mirror

Because the chromosomal deletion is a fixed genetic state, no therapy can restore the missing material; management is therefore entirely symptomatic and supportive. Given the high rate of kidney involvement, routine renal monitoring is essential, with particular vigilance around nephrotoxic agents such as lithium. The elevated diabetes risk demands careful surveillance in kidney transplant recipients for post-transplantation diabetes mellitus, and in psychiatric patients for the weight gain and metabolic effects of neuroleptic medications. A rarer counterpart, 17q12 microduplication syndrome, involves the addition rather than removal of material in the same chromosomal region and occurs roughly one-fifth as often. Its phenotype is equally broad—ranging from no symptoms to severe disability—with intellectual impairment often more pronounced but physical health frequently better than in the deletion. Epilepsy is common, a single case of sex reversal has been documented, and autism, while reported, appears considerably less frequent. Physical findings include syndactyly, microcephaly, and thick eyebrows or a unibrow. The duplication shows low penetrance, with many carriers inheriting it from entirely asymptomatic parents.

Gallery